APHM, Timone Hospital, Epileptology and Cerebral Rhythmology, Marseille, France; Aix Marseille Univ, CNRS, CRMBM, Marseille, France; APHM, Timone Hospital, CEMEREM, Marseille, France.
Aix Marseille Univ, CNRS, CRMBM, Marseille, France; APHM, Timone Hospital, CEMEREM, Marseille, France.
Clin Neurophysiol. 2022 Jan;133:94-103. doi: 10.1016/j.clinph.2021.10.012. Epub 2021 Nov 10.
Amygdala enlargement is increasingly described in association with temporal lobe epilepsies. Its significance, however, remains uncertain both in terms of etiology and its link with psychiatric disorders and of its involvement in the epileptogenic zone. We assessed the epileptogenic networks underlying drug-resistant epilepsy with amygdala enlargement and investigated correlations between clinical features, epileptogenicity and morphovolumetric amygdala characteristics.
We identified 12 consecutive patients suffering from drug-resistant epilepsy with visually suspected amygdala enlargement and available stereoelectroencephalographic recording. The epileptogenic zone was defined using the Connectivity Epileptogenicity Index. Morphovolumetric measurements were performed using automatic segmentation and co-registration on the 7TAMIbrain Amygdala atlas.
The epileptogenic zone involved the enlarged amygdala in all but three cases and corresponded to distributed, temporal-insular, temporal-insular-prefrontal or prefrontal-temporal networks in ten cases, while only two were temporo-mesial networks. Morphovolumetrically, amygdala enlargement was bilateral in 75% of patients. Most patients presented psychiatric comorbidities (anxiety, depression, posttraumatic stress disorder). The level of depression defined by screening questionnaire was positively correlated with the extent of amygdala enlargement.
Drug-resistant epilepsy with amygdala enlargement is heterogeneous; most cases implied "temporal plus" networks.
The enlarged amygdala could reflect an interaction of stress-mediated limbic network alterations and mechanisms of epileptogenesis.
杏仁核增大与颞叶癫痫越来越多地相关联。然而,无论是在病因学方面,还是在与精神障碍的联系方面,或者在其与致痫区的关系方面,其意义仍然不确定。我们评估了伴有杏仁核增大的耐药性癫痫的致痫网络,并研究了临床特征、致痫性和形态体积杏仁核特征之间的相关性。
我们确定了 12 例连续的药物难治性癫痫患者,这些患者视觉上怀疑有杏仁核增大且有可用的立体脑电图记录。使用连通性致痫性指数定义致痫区。使用自动分割和在 7TAMIbrain 杏仁核图谱上的配准进行形态体积测量。
除了三个病例之外,所有病例的致痫区都涉及增大的杏仁核,十个病例的致痫区对应于分布式、颞叶-岛叶、颞叶-岛叶-前额叶或前额叶-颞叶网络,而只有两个是颞叶内侧网络。形态学上,75%的患者的杏仁核增大是双侧的。大多数患者存在精神共病(焦虑、抑郁、创伤后应激障碍)。通过筛查问卷定义的抑郁程度与杏仁核增大的程度呈正相关。
伴有杏仁核增大的耐药性癫痫是异质性的;大多数病例涉及“颞叶加”网络。
增大的杏仁核可能反映了应激介导的边缘网络改变和致痫机制的相互作用。